A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Recruiting · NCT05775523 · Registry updated 2026-02-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin | Bone Diseases, Developmental, Bone Diseases, Endocrine, Dwarfism, Failure to Thrive, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, bone disorder, brain disorder, central nervous system disorder, endocrine system disorder, hypopituitarism, hypothalamic disorder, musculoskeletal system disorder, nervous system disorder, pituitary dwarfism, pituitary gland disorder | Recruiting | Not stated | 2026-02-04 | NCT05775523 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ascendis Pharma Endocrinology Division A/S | 4 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||